SCHEMBL27035950

SCHEMBL27035950

O=S(=O)(Cl)c1csc2nc(Cl)ccc12

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26977837 0.85 — —
SCHEMBL26978104 0.81 — —
SCHEMBL30559681 0.78 TRPV4 (0.34) —
SCHEMBL26978025 0.78 TRPV4 (0.34) —
SCHEMBL7020692 0.72 TRPV4 (0.41) —
SCHEMBL31221676 0.71 IDO1 (0.39) —
SCHEMBL27040617 0.69 CDC7 (0.32) —
SCHEMBL357264 0.69 DHODH (0.39) —
SCHEMBL31507111 0.69 CDC7 (0.32) —
SCHEMBL17368 0.67 TRPV4 (0.37) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4744661-A2 NOVEL PYRIMIDIN-2-YL SULFONAMIDE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2026-05-20 — — EP disclosed
EP-4298092-B1 NOVEL PYRIMIDIN-2-YL SULFONAMIDE DERIVATIVES HOFFMANN LA ROCHE (CH) 2025-11-26 — — EP disclosed
US-20240025883-A1 PYRIMIDIN-2-YL SULFONAMIDE DERIVATIVES HOFFMANN-LA ROCHE INC. (US) 2024-01-25 — — US disclosed
Send feedback